Larval therapy for leg ulcers (VenUS II): randomised controlled trial
Top Cited Papers
Open Access
- 19 March 2009
- Vol. 338 (mar19 2) , b773
- https://doi.org/10.1136/bmj.b773
Abstract
Objective To compare the clinical effectiveness of larval therapy with a standard debridement technique (hydrogel) for sloughy or necrotic leg ulcers. Design Pragmatic, three armed randomised controlled trial. Setting Community nurse led services, hospital wards, and hospital outpatient leg ulcer clinics in urban and rural settings, United Kingdom. Participants 267 patients with at least one venous or mixed venous and arterial ulcer with at least 25% coverage of slough or necrotic tissue, and an ankle brachial pressure index of 0.6 or more. Interventions Loose larvae, bagged larvae, and hydrogel. Main outcome measures The primary outcome was time to healing of the largest eligible ulcer. Secondary outcomes were time to debridement, health related quality of life (SF-12), bacterial load, presence of meticillin resistant Staphylococcus aureus, adverse events, and ulcer related pain (visual analogue scale, from 0 mm for no pain to 150 mm for worst pain imaginable). Results Time to healing was not significantly different between the loose or bagged larvae group and the hydrogel group (hazard ratio for healing using larvae v hydrogel 1.13, 95% confidence interval 0.76 to 1.68; P=0.54). Larval therapy significantly reduced the time to debridement (2.31, 1.65 to 3.2; Pv 50% (3/6); P=0.34), although this comparison was underpowered. Mean ulcer related pain scores were higher in either larvae group compared with hydrogel (mean difference in pain score: loose larvae v hydrogel 46.74 (95% confidence interval 32.44 to 61.04), Pv hydrogel 38.58 (23.46 to 53.70), PConclusions Larval therapy did not improve the rate of healing of sloughy or necrotic leg ulcers or reduce bacterial load compared with hydrogel but did significantly reduce the time to debridement and increase ulcer pain. Trial registration Current Controlled Trials ISRCTN55114812 and National Research Register N0484123692.Keywords
This publication has 29 references indexed in Scilit:
- Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 2007
- Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericataMedical and Veterinary Entomology, 2007
- Promotion of Human Dermal Fibroblast Migration, Matrix Remodelling and Modification of Fibroblast Morphology within a Novel 3D Model by Lucilia sericata Larval SecretionsJournal of Investigative Dermatology, 2006
- Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin‐coated surfaceWound Repair and Regeneration, 2005
- In the SpotlightAdvances in Skin & Wound Care, 2005
- Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA)Microbes and Infection, 2004
- Maggots and wound healing: an investigation of the effects of secretions fromLucilia sericatalarvae upon interactions between human dermal fibroblasts and extracellular matrix componentsBritish Journal of Dermatology, 2003
- Destruction of Bacteria in the Digestive Tract of the Maggot ofLucilia sericata(Diptera: Calliphoridae)Journal of Medical Entomology, 2001
- Growth effects of Phaenicia sericata larval extracts on fibroblasts: Mechanism for wound healing by maggot therapyLife Sciences, 1997
- Analysis of serial measurements in medical research.BMJ, 1990